Search

Elizabeth Kemmerer

Examiner (ID: 7452, Phone: (571)272-0874 , Office: P/1646 )

Most Active Art Unit
1646
Art Unit(s)
1804, 1616, 1674, 1801, 1646, 1812
Total Applications
1810
Issued Applications
1112
Pending Applications
139
Abandoned Applications
581

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12637452 [patent_doc_number] => 20180104314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY [patent_app_type] => utility [patent_app_number] => 15/606273 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12021 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606273 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/606273
STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY May 25, 2017 Abandoned
Array ( [id] => 11956379 [patent_doc_number] => 20170260529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING' [patent_app_type] => utility [patent_app_number] => 15/603777 [patent_app_country] => US [patent_app_date] => 2017-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 38156 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603777 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/603777
POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING May 23, 2017 Abandoned
Array ( [id] => 12637050 [patent_doc_number] => 20180104180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => THERMO-SENSITIVE BONE GROWTH COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 15/602941 [patent_app_country] => US [patent_app_date] => 2017-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10108 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602941 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/602941
THERMO-SENSITIVE BONE GROWTH COMPOSITIONS May 22, 2017 Abandoned
Array ( [id] => 12022294 [patent_doc_number] => 20170312392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'Tissue Engineering Methods and Compositions' [patent_app_type] => utility [patent_app_number] => 15/596623 [patent_app_country] => US [patent_app_date] => 2017-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26229 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15596623 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/596623
Tissue Engineering Methods and Compositions May 15, 2017 Abandoned
Array ( [id] => 12728785 [patent_doc_number] => 20180134762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => OSTEOGENIC PROTEINS [patent_app_type] => utility [patent_app_number] => 15/587708 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32095 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587708 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/587708
Osteogenic proteins May 4, 2017 Issued
Array ( [id] => 14519131 [patent_doc_number] => 10336812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-02 [patent_title] => GDF15 fusion proteins and uses thereof [patent_app_type] => utility [patent_app_number] => 15/586463 [patent_app_country] => US [patent_app_date] => 2017-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 27090 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586463 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/586463
GDF15 fusion proteins and uses thereof May 3, 2017 Issued
Array ( [id] => 17556090 [patent_doc_number] => 11312766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-26 [patent_title] => Antibodies against growth differentiation factor 15 and uses thereof [patent_app_type] => utility [patent_app_number] => 16/096579 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 49322 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096579 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/096579
Antibodies against growth differentiation factor 15 and uses thereof Apr 25, 2017 Issued
Array ( [id] => 16979027 [patent_doc_number] => 20210223264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => DIAGNOSTIC METHOD(S) FOR DETECTING AND TREATING POST-INFARCT MYOCARDIUM REMODELING AND DIFFUSE MYOCARDIAL FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/096696 [patent_app_country] => US [patent_app_date] => 2017-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096696 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/096696
DIAGNOSTIC METHOD(S) FOR DETECTING AND TREATING POST-INFARCT MYOCARDIUM REMODELING AND DIFFUSE MYOCARDIAL FIBROSIS Apr 24, 2017 Abandoned
Array ( [id] => 11977607 [patent_doc_number] => 20170281761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'METHOD OF TREATING ALVELOR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 15/494121 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23114 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494121 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/494121
Method of treating alvelor bone loss through the use of anti-sclerostin antibodies Apr 20, 2017 Issued
Array ( [id] => 12239938 [patent_doc_number] => 20180072801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION' [patent_app_type] => utility [patent_app_number] => 15/492782 [patent_app_country] => US [patent_app_date] => 2017-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34263 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492782 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/492782
ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION Apr 19, 2017 Abandoned
Array ( [id] => 12001872 [patent_doc_number] => 20170306027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'ALK7 ANTAGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/480726 [patent_app_country] => US [patent_app_date] => 2017-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 73162 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480726 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/480726
ALK7 ANTAGONISTS AND USES THEREOF Apr 5, 2017 Abandoned
Array ( [id] => 12584931 [patent_doc_number] => 20180086806 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2018-03-29 [patent_title] => BMPRII POLYPEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/480275 [patent_app_country] => US [patent_app_date] => 2017-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480275 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/480275
BMPRII POLYPEPTIDES AND USES THEREOF Apr 4, 2017 Abandoned
Array ( [id] => 12584931 [patent_doc_number] => 20180086806 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2018-03-29 [patent_title] => BMPRII POLYPEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/480275 [patent_app_country] => US [patent_app_date] => 2017-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480275 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/480275
BMPRII POLYPEPTIDES AND USES THEREOF Apr 4, 2017 Abandoned
Array ( [id] => 16389518 [patent_doc_number] => 20200330459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES [patent_app_type] => utility [patent_app_number] => 16/089842 [patent_app_country] => US [patent_app_date] => 2017-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089842 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/089842
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES Apr 4, 2017 Abandoned
Array ( [id] => 11756055 [patent_doc_number] => 20170202922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'TARGETED CARGO PROTEIN COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 15/473446 [patent_app_country] => US [patent_app_date] => 2017-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19193 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473446 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/473446
TARGETED CARGO PROTEIN COMBINATION THERAPY Mar 28, 2017 Abandoned
Array ( [id] => 11729312 [patent_doc_number] => 20170190756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'RECOMBINANT NEL-LIKE (NELL) PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 15/462682 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 17478 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462682 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/462682
RECOMBINANT NEL-LIKE (NELL) PROTEIN PRODUCTION Mar 16, 2017 Abandoned
Array ( [id] => 11713661 [patent_doc_number] => 20170182160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'METHODS OF TREATING ATOPIC DERMATITIS WITH IL-31 MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 15/455278 [patent_app_country] => US [patent_app_date] => 2017-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 37969 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455278 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/455278
Methods of treating atopic dermatitis with IL-31 monoclonal antibodies Mar 9, 2017 Issued
Array ( [id] => 12001877 [patent_doc_number] => 20170306031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'BINDING PROTEINS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/449839 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 98 [patent_figures_cnt] => 98 [patent_no_of_words] => 100242 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449839 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449839
Binding proteins and methods of use thereof Mar 2, 2017 Issued
Array ( [id] => 14145467 [patent_doc_number] => 10253092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Medicament and apparatus for treating chronic kidney disease [patent_app_type] => utility [patent_app_number] => 15/436139 [patent_app_country] => US [patent_app_date] => 2017-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 5919 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436139 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/436139
Medicament and apparatus for treating chronic kidney disease Feb 16, 2017 Issued
Array ( [id] => 11943288 [patent_doc_number] => 20170247439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'METHODS FOR TREATING OSTEOGENESIS IMPERFECTA' [patent_app_type] => utility [patent_app_number] => 15/427920 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 20996 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427920 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/427920
Methods for treating osteogenesis imperfecta Feb 7, 2017 Issued
Menu